Wells Fargo & Company Cellectis S.A. Transaction History

Wells Fargo & Company

$410 Billion
Q1 2024

A detailed history of Wells Fargo & Company transactions in Cellectis S.A. stock. As of the latest transaction made, Wells Fargo & Company holds 12,940 shares of CLLS stock, worth $26,397. This represents 0.0% of its overall portfolio holdings.

Number of Shares

12,940

Previous 14,294 9.47%

Holding current value

$26,397

Previous $44,000 22.73%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$2.41 - $3.09 $3,263 - $4,183	-1,354 Reduced 9.47%	12,940 $34,000
Q4 2023 Feb 09, 2024	SELL	$0.97 - $3.55 $1,212 - $4,437	-1,250 Reduced 8.04%	14,294 $44,000
Q3 2023 Nov 13, 2023	SELL	$1.58 - $2.86 $592 - $1,072	-375 Reduced 2.36%	15,544 $24,000
Q2 2023 Aug 15, 2023	SELL	$1.72 - $2.12 $963 - $1,187	-560 Reduced 3.4%	15,919 $31,000
Q1 2023 May 12, 2023	SELL	$1.83 - $3.84 $915 - $1,920	-500 Reduced 2.94%	16,479 $31,000

Q4 2022 Feb 13, 2023	SELL	$1.85 - $2.53 $462 - $632	-250 Reduced 1.45%	16,979 $35,000
Q3 2022 Nov 14, 2022	BUY	$2.42 - $4.08 $13,068 - $22,032	5,400 Added 45.65%	17,229 $40,000
Q2 2022 Aug 12, 2022	SELL	$2.39 - $4.93 $2,629 - $5,423	-1,100 Reduced 8.51%	11,829 $33,000
Q1 2022 May 16, 2022	SELL	$3.45 - $8.77 $22,573 - $57,382	-6,543 Reduced 33.6%	12,929 $59,000
Q4 2021 Feb 14, 2022	SELL	$8.01 - $12.84 $113,325 - $181,660	-14,148 Reduced 42.08%	19,472 $158,000
Q3 2021 Nov 15, 2021	BUY	$11.94 - $16.09 $55,998 - $75,462	4,690 Added 16.21%	33,620 $423,000
Q2 2021 Aug 16, 2021	SELL	$14.36 - $20.93 $22,143 - $32,274	-1,542 Reduced 5.06%	28,930 $448,000
Q1 2021 May 13, 2021	BUY	$18.19 - $33.25 $66,211 - $121,030	3,640 Added 13.57%	30,472 $616,000
Q4 2020 Feb 09, 2021	SELL	$15.87 - $31.64 $21,662 - $43,188	-1,365 Reduced 4.84%	26,832 $726,000
Q3 2020 Nov 05, 2020	SELL	$15.7 - $20.84 $41,934 - $55,663	-2,671 Reduced 8.65%	28,197 $522,000
Q2 2020 Aug 13, 2020	SELL	$8.21 - $21.02 $58,980 - $151,007	-7,184 Reduced 18.88%	30,868 $550,000
Q1 2020 May 14, 2020	BUY	$7.81 - $18.82 $297,186 - $716,138	38,052 New	38,052 $350,000

Others Institutions Holding CLLS

# of Institutions

Shares Held

9.83M

Call Options Held

Put Options Held

30.9K

View Full List

About Cellectis S.A.

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $92.8M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

More about CLLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Cellectis S.A. Transaction History